|
|
|
|
|
by toomuchtodo
809 days ago
|
|
GLP-1 agonists (Wegovy, Ozempic, semaglutide), help people who have a brain chemistry preventing calorie reduction success naturally (willpower or whatever you want to call it). The gene therapy trials should be done soon. At that point, the flywheel comes up to speed and starts enabling susceptible populations with the genetic bug to fix it, in order to have agency against a system designed to shovel them garbage for profit. Obesity at this scale is a system failure, so you have to fix the system (and it’s clearly not going to be done at the regulatory or corp level). (You can absolutely blame them for making people fat; some people cannot control it, and you cannot blame someone for their brain chemistry) |
|
I am not comfortable with the idea of mass-medicating to try to solve these societal issues through a brain chemistry strategy.